Skip Navigation

Link to  the National Institutes of Health NIDA NEWS NIDA News RSS Feed
The Science of Drug Abuse and Addiction from the National Institute on Drug Abuse Keep Your Body Healthy
Go to the Home pageGo to the About Nida pageGo to the News pageGo to the Meetings & Events pageGo to the Funding pageGo to the Publications page
PhysiciansResearchersParents/TeachersStudents/Young AdultsEn Español Drugs of Abuse & Related Topics

NIDA Home > Publications > Research Monographs >    

Pharmacokinetics, Metabolism, and Pharmaceutics of Drugs of Abuse



NIDA Research Monograph, Number 173 [Printed in 1997]

Get Adobe Reader

Complete Monograph - Monograph173.pdf (4.6 MB)


Click on link to go page

Table of Contents

Introduction-----1
Rao S. Rapaka, Nora Chiang, and Billy R. Martin

The Potential Role of the Cytochrome P-450 2D6 Pharmacogenetic Polymorphism in Drug Abuse-----6
Edward M. Sellers, S. Victoria Otton, and Rachel F. Tyndale

Human Liver Cocaine Carboxylesterases-----27
William F. Bosron, Robert A. Dean, Monica R. Brzezinski, and Evgenia V. Pindel

Effects of Ethanol on Cocaine Metabolism and Disposition in the Rat-----35
Robert A. Dean, William F. Bosron, Frederick M. Zachman, Jing Zhang, and Monica R. Brzezinski

Individual Differences in Nicotine Kinetics and Metabolism in Humans-----48
Neal L. Benowitz and Peyton Jacob III

Inhibitors of Anandamide Breakdown-----65
Dale G. Deutsch and Alexandros Makriyannis

Metabolic Bioactivation Reactions Potentially Related to Drug Toxicities-----85
Neal Castagnoli, Jr. and Kay P. Castagnoli

The Role of Iminium-Enamine Species in the Toxication and Detoxication of Cyclic Tertiary Amines-----106
Lawrence M. Sayre, David A. Engelhart, Durgesh V. Nadkarni, M.K. Manoj Babu, Ann Marie Flammang, and G. David McCoy

Neurotoxicity of Amphetamines and Their Metabolites-----128
James W. Gibb, Michel Johnson, Ikram Elayan, Heng Keang Lim, Lisa Matsuda, and Glen R. Hanson

Potential New Insights Into the Molecular Mechanisms of Methamphetamine-Induced Neurodegeneration-----146
Monika Z. Wrona, Zhaoliang Yang, Fa Zhang, and Glenn Dryhurst

Immunotoxicology of Opioids, Inhalants, and Other Drugs of Abuse-----175
Robert V. House, Peter T. Thomas, and Hemendra N. Bhargava

Inhalation Studies With Drugs of Abuse-----201
Yun Meng, Aron H. Lichtman, D. Troy Bridgen, and Billy R. Martin

Biocatalysts in Detoxication of Drugs of Abuse-----225
John R. Cashman

Antibodies as Pharmacokinetic and Metabolic Modifiers of Neurotoxicity-----259
S. Michael Owens

Toxicokinetics in the National Toxicology Program-----273
Thomas J. Goehl

Ordering Information-----305




NIDA Home | Site Map | Search | FAQs | Accessibility | Privacy | FOIA (NIH) | Employment | Print Version


National Institutes of Health logo_Department of Health and Human Services Logo The National Institute on Drug Abuse (NIDA) is part of the National Institutes of Health (NIH) , a component of the U.S. Department of Health and Human Services. Questions? See our Contact Information. Last updated on Tuesday, July 22, 2008. The U.S. government's official web portal